Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Lipoatrophy in patients with multiple sclerosis on glatiramer acetate.
[Epidemiology of multiple sclerosis in the Primosky Krai and Far East regions.]
Solitary sclerosis: Progressive neurological deficit from a spatially isolated demyelinating lesion: A further report.
Sublime Microglia: Expanding Roles for the Guardians of the CNS.
Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis.
Progressive outer retinal necrosis in a multiple sclerosis patient on natalizumab.
Mechanism for p38α-mediated experimental autoimmune encephalomyelitis.
Improving Hand Functional Use in Subjects with Multiple Sclerosis Using a Musical Keyboard: A Randomized Controlled Trial.
Information on natalizumab (marketed as Tysabri)
From "Wheelchair Circuit" to "Wheelchair Assessment Instrument for People with Multiple Sclerosis": Reliability and Validity Analysis of a Test to Assess Driving Skills in Manual Wheelchair Users With Multiple Sclerosis.
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
Lessons from Jack Griffin and the "pathogenesis of peripheral nerve disease".
Decreased Frontal Lobe Gray Matter Perfusion in Cognitively Impaired Patients with Secondary-Progressive Multiple Sclerosis Detected by the Bookend Technique.
High levels of cerebrospinal fluid free kappa chains predict conversion to multiple sclerosis.
CD4 cell response to interval therapy with natalizumab.
Evaluation of sexual function in women at two stages of multiple sclerosis.
The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis.
Oligodendrocytes and the early multiple sclerosis lesion.
Unraveling the secrets of white matter - Bridging the gap between cellular, animal and human imaging studies.
Myelin Basic Protein-Specific TCR/HLA-DRB5*01:01 Transgenic Mice Support the Etiologic Role of DRB5*01:01 in Multiple Sclerosis.
Motor impairments at presentation of clinically isolated syndrome suggestive of multiple sclerosis: Characterization of different disease subtypes.
Nerve Conduction Velocity Is Regulated by the Inositol Polyphosphate-4-Phosphatase II Gene.
Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis.
A gender-related action of IFNbeta-therapy was found in multiple sclerosis.
Teva to initiate third Phase III trial of oral laquinimod for the treatment of relapsing remitting multiple sclerosis
Pages
« first
‹ previous
…
117
118
119
120
121
122
123
124
125
…
next ›
last »